PharmaCog developed new models to predict the efficacy of drug candidates by combining past and current data to define a series of biomarkers of dementia progression. The project proposed to the pharmaceutical industry and academic research laboratories new methods for successfully developing new drugs for the treatment of Alzheimer's disease. The outcomes of the project should pave the way for delivering new drugs that will improve patients' cognitive and behavioural symptoms and slow the progression of the disease. This should also reduce the economic and social burden of the disease. PharmaCog researchers worked to develop animal models that more closely mimic Alzheimer's disease in humans: it is hoped that these models may be better at predicting how effective the drug will be in humans.
Last Updated: Tuesday 05 January 2016